Computational Affinity between Anthraquinone Derivatives and DNA
Overview
Targeting DNA is a viable solution to treating cancer. Although many DNA intercalators are effective, they have deleterious effects on DNA structure and negative side effects for the patient. Anthraquinone drugs are used to manage symptoms of multiple sclerosis, fight antibacterial infections, and can facilitate tumorigenesis. Unlike DNA intercalators, anthraquinones interact with DNA using major and minor grooves which limit DNA disruption. In this study, the binding affinity of 4 anthraquinone derivatives: 9-aminoacridine (9-AA), 4-aminopyridine (4-AP), 3ß-cholesteryl N-(9-acridinyl) carbamate, 3ß-cholesteryl N-(4-pyridyl) carbamate was explored. AutoDock Vina determined the impact of anthraquinone size, polarity and lipophilicity on the binding affinity. In addition, the drug-like properties of the anthraquinones were calculated using the SwissADME webserver. The structure of DNA strand was obtained from the Protein Data Bank (1BDN). The study hypothesized that the binding will be stronger as polarity and number hydrogen bond donors and acceptors in the ligands increase. Our preliminary data indicates anthraquinones with cholesterol have a stronger affinity with DNA. The computed affinities for each ligand (9-acrininyl, 4-pyridyl, 9-AA, and 4-AP) are 17.34 kcal/mol, -16.00 kcal/mol, -12.60 kcal/mol, and -7.38 kcal/mol respectively. All the ligands studied mostly preferred the minor groove. The affinity between 9-AA and 4-AP with DNA is dominated by electrostatics and hydrogen bonds. In addition to electrostatics in 9-acrininyl and 4-pyridyl, binding seems to be enhanced by van Der Waals interactions through cholesterol hydrophobic patches. This data suggest that cholesterol has a major impact in enhancing the affinity between DNA and anthraquinones.
Competition history
- ISEF 2020
Resources
Related projects
JSHS · 2025
Synthesis and Docking of Drug Delivery Anthraquinonylalkanamides
ISEF · 2014
Study of Binding Modes of Synthetic Coumarin Derivates with DNA and Albumin
ISEF · 2024
DNA Crystallography: Exploring Small-Molecule Interactions With DNA for a Novel Nanoscale Drug Delivery Platform
ISEF · 2023
Targeting Drug Resistant Cancer Cells by Plant Based Bio-Active Compounds
JSHS · 2022
In silico Design of APOBEC3G Inhibitors Through Site-Specific Fluorination of a ssDNA Oligonucleotide
ISEF · 2018
Computational Predictions in the Design of Affinity-Based Drug Delivery
JSHS · 2025
AI-Mediated Computational Analysis of RNA-Based Aptamers Targeting the CD133+ Glioblastoma Cells
ISEF · 2025
Engineering DNA Nanocrystals for Trigger-Responsive Drug Delivery: A Biocompatible Approach to Nanomedicine
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair